Toydemir, P. Et Al. 2001. Assessment of prothrombotic risk in patients with Behcet's disease should include homocysteine plasma levels - Reply. JOURNAL OF RHEUMATOLOGY , vol.28, no.12 , 2765.

Toydemir, P., ELHAN, A. H., Tukun, A., Toydemir, R., Gurler, A., Tuzuner, A., ... Bokesoy, I.(2001). Assessment of prothrombotic risk in patients with Behcet's disease should include homocysteine plasma levels - Reply. JOURNAL OF RHEUMATOLOGY , vol.28, no.12, 2765.

Toydemir, PB Et Al. "Assessment of prothrombotic risk in patients with Behcet's disease should include homocysteine plasma levels - Reply," JOURNAL OF RHEUMATOLOGY , vol.28, no.12, 2765, 2001

Toydemir, PB Et Al. "Assessment of prothrombotic risk in patients with Behcet's disease should include homocysteine plasma levels - Reply." JOURNAL OF RHEUMATOLOGY , vol.28, no.12, pp.2765, 2001

Toydemir, P. Et Al. (2001) . "Assessment of prothrombotic risk in patients with Behcet's disease should include homocysteine plasma levels - Reply." JOURNAL OF RHEUMATOLOGY , vol.28, no.12, p.2765.

@article{article, author={PB Toydemir Et Al. }, title={Assessment of prothrombotic risk in patients with Behcet's disease should include homocysteine plasma levels - Reply}, journal={JOURNAL OF RHEUMATOLOGY}, year=2001, pages={2765} }